Drugs Affecting Neurotransmitter Release or Uptake - Concept | Pharmacology | JoVe

S'identifier

Some drugs that act on the adrenergic neurons can disrupt catecholamine release from synaptic vesicles or interfere with neurotransmitter reuptake.

Reserpine, an alkaloid, blocks the transport of catecholamine into synaptic vesicles, leading to the accumulation of catecholamines in the cytosol. Eventually, they are degraded by MAO, reducing sympathetic transmission.

Guanethidine, a sympatholytic agent, enters the nerve endings and accumulates in synaptic vesicles, displacing noradrenaline. This impedes vesicular exocytosis and neurotransmitter release at the synapse, blocking impulse conduction.

Higher doses of guanethidine can cause structural aberrations in the neuron.

Noradrenaline, when released into the synaptic space, undergoes reuptake via the norepinephrine transporter. Inhibitors of this transporter include serotonin-noradrenaline reuptake inhibitors like duloxetine, tricyclic antidepressants like imipramine, and indirect-acting agonists like cocaine.

Due to their associated side effects, these drugs have limited therapeutic use and have been largely replaced by more selective agents.

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking neurotransmitter release and uptake by targeting the catecholamine transporter NET. It can also enter synaptic vesicles and displace noradrenaline. Some other drugs like duloxetine, imipramine, and cocaine also inhibit this transporter. Cocaine, in particular, enhances sympathetic activity by obstructing the reuptake of catecholamines. While these drugs have been studied experimentally, only a few have been used clinically. Newer and more selective drugs have made some of these compounds outdated. However, understanding how these drugs affect the release and reuptake of catecholamines is essential for potential treatments of various disorders.

Tags

Neurotransmitters Catecholamines Sympathetic Transmission Reserpine Vesicular Monoamine Transporter VMAT Guanethidine Norepinephrine Transporter NET Duloxetine Imipramine Cocaine Reuptake Inhibition Drug Effects Clinical Use

Du chapitre 6:

article

Now Playing

6.17 : Drugs Affecting Neurotransmitter Release or Uptake

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

876 Vues

article

6.1 : Neurones adrénergiques : Neurotransmission

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

3.2K Vues

article

6.2 : Récepteurs adrénergiques (récepteurs adrénergiques) : classification

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.1K Vues

article

6.3 : Récepteurs adrénergiques : ɑ Sous-type

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.3K Vues

article

6.4 : Récepteurs adrénergiques : sous-type β

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.4K Vues

article

6.5 : Agonistes adrénergiques : agents à action directe

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.3K Vues

article

6.6 : Agonistes adrénergiques : agents à action indirecte

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.4K Vues

article

6.7 : Agonistes adrénergiques : agents à action mixte

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

625 Vues

article

6.8 : Agonistes adrénergiques : chimie et relation structure-activité

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.5K Vues

article

6.9 : Agonistes adrénergiques : classification thérapeutique

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

626 Vues

article

6.10 : Agonistes adrénergiques : utilisations thérapeutiques

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

685 Vues

article

6.11 : Antagonistes adrénergiques : chimie et classification des inhibiteurs des récepteurs ɑ

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

758 Vues

article

6.12 : Antagonistes adrénergiques : actions pharmacologiques des inhibiteurs des récepteurs ɑ

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

506 Vues

article

6.13 : Antagonistes adrénergiques : chimie et classification des antagonistes des récepteurs β

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

458 Vues

article

6.14 : Antagonistes adrénergiques : actions pharmacologiques des antagonistes des récepteurs β

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

487 Vues

See More

Copyright © 2025 MyJoVE Corporation. Tous droits réservés.